{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:20:29Z","timestamp":1780323629558,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Anesth"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00540-019-02643-3","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T08:04:47Z","timestamp":1556179487000},"page":"543-550","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The efficacy and safety of prophylactic use of levosimendan on patients undergoing coronary artery bypass graft: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"33","author":[{"given":"Wanyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshuang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,25]]},"reference":[{"key":"2643_CR1","first-page":"726158","volume":"2014","author":"M Diodato","year":"2014","unstructured":"Diodato M, Chedrawy EG. Coronary artery bypass graft surgery: the past, present, and future of myocardial revascularisation. Surg Res Pract. 2014;2014:726158.","journal-title":"Surg Res Pract."},{"key":"2643_CR2","volume-title":"Trends in operating room procedures in US Hospitals, 2001\u20132011: statistical brief #171. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs","author":"AJ Weiss","year":"2006","unstructured":"Weiss AJ, Elixhauser A. Trends in operating room procedures in US Hospitals, 2001\u20132011: statistical brief #171. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Agency for Healthcare Research and Quality (US): Rockville; 2006."},{"issue":"7","key":"2643_CR3","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1136\/heart.89.7.767","volume":"89","author":"L Nalysnyk","year":"2003","unstructured":"Nalysnyk L, Fahrbach K, Reynolds MW, Zhao SZ, Ross S. Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis. Heart. 2003;89(7):767\u201372.","journal-title":"Heart."},{"issue":"2","key":"2643_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/cc8153","volume":"14","author":"A Mebazaa","year":"2010","unstructured":"Mebazaa A, Pitsis AA, Rudiger A, Toller W, Longrois D, Ricksten SE, Bobek I, De Hert S, Wieselthaler G, Schirmer U, von Segesser LK, Sander M, Poldermans D, Ranucci M, Karpati PC, Wouters P, Seeberger M, Schmid ER, Weder W, Follath F. Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery. Crit Care. 2010;14(2):201.","journal-title":"Crit Care."},{"issue":"5","key":"2643_CR5","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.athoracsur.2011.06.017","volume":"92","author":"KD Algarni","year":"2011","unstructured":"Algarni KD, Maganti M, Yau TM. Predictors of low cardiac output syndrome after isolated coronary artery bypass surgery: trends over 20 years. Ann Thor Surg. 2011;92(5):1678\u201384.","journal-title":"Ann Thor Surg."},{"issue":"11","key":"2643_CR6","first-page":"559","volume":"73","author":"G Landoni","year":"2007","unstructured":"Landoni G, Bove T, Crivellari M, Poli D, Fochi O, Marchetti C, Romano A, Marino G, Zangrillo A. Acute renal failure after isolated CABG surgery: 6 years of experience. Minerva Anestesiol. 2007;73(11):559\u201365.","journal-title":"Minerva Anestesiol."},{"key":"2643_CR7","unstructured":"Vela JP, Rivera JJ, Llorente MA, de Marcos BG, Torrado H, Laborda CG, Zamora MF, Fern\u00e1ndez FG, Ben\u00edtez JM. Low cardiac output syndrome in the postoperative period of cardiac surgery. Profile, differences in clinical course and prognosis. The ESBAGA study. Med Intensiva. 2018;42(3):159-6."},{"issue":"6","key":"2643_CR8","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1097\/ALN.0b013e318173026f","volume":"108","author":"JL Fellahi","year":"2008","unstructured":"Fellahi JL, Parienti JJ, Hanouz JL, Plaud B, Riou B, Ouattara A. Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome propensity-adjusted analyses. Anesthesiology. 2008;108(6):979\u201387. \n                              https:\/\/doi.org\/10.1097\/ALN.0b013e318173026f\n                              \n                           .","journal-title":"Anesthesiology."},{"issue":"5","key":"2643_CR9","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1097\/ALN.0000000000000224","volume":"120","author":"DV Nielsen","year":"2014","unstructured":"Nielsen DV, Hansen MK, Johnsen SP, Hansen M, Hindsholm K, Jakobsen CJ. Health outcomes with and without use of inotropic therapy in cardiac surgery: results of a propensity score-matched analysis. Anesthesiology. 2014;120(5):1098\u2013108. \n                              https:\/\/doi.org\/10.1097\/ALN.0000000000000224\n                              \n                           .","journal-title":"Anesthesiology."},{"issue":"3","key":"2643_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1006\/jmcc.1999.1093","volume":"32","author":"J Levijoki","year":"2000","unstructured":"Levijoki J, Pollesello P, Kaivola J, Tilgmann C, Sorsa T, Annila A, Kilpel\u00e4inen I, Haikala H. Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan: structure-response and binding analysis with analogs of levosimendan. J Mol Cell Cardiol. 2000;32(3):479\u201391.","journal-title":"J Mol Cell Cardiol."},{"issue":"4","key":"2643_CR11","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1053\/euhj.1997.0806","volume":"19","author":"J Lilleberg","year":"1998","unstructured":"Lilleberg J, Nieminen MS, Akkila J, Heikkil\u00e4 L, Kuitunen A, Lehtonen L, Verkkala K, Mattila S, Salmenper\u00e4 M. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J. 1998;19(4):660\u20138.","journal-title":"Eur Heart J."},{"issue":"5","key":"2643_CR12","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0009-9236(97)90139-9","volume":"61","author":"H Ukkonen","year":"1997","unstructured":"Ukkonen H, Saraste M, Akkila J, Knuuti MJ, Lehikoinen P, N\u00e5gren K, Lehtonen L, Voipio-Pulkki LM. Myocardial efficiency during calcium sensitization with levosimendan: a noninvasive study with positron emission tomography and echocardiography in healthy volunteers. Clin Pharmacol Thera. 1997;61(5):596\u2013607.","journal-title":"Clin Pharmacol Thera."},{"issue":"1","key":"2643_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/bjp.2008.52","volume":"154","author":"EF Toit du","year":"2008","unstructured":"du Toit EF, Genis A, Opie LH, Pollesello P, Lochner A. A role for the RISK pathway and K(ATP) channels in pre- and post-conditioning induced by levosimendan in the isolated guinea pig heart. Br J Pharmacol. 2008;154(1):41\u201350.","journal-title":"Br J Pharmacol."},{"issue":"2\u20133","key":"2643_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0014-2999(01)00997-9","volume":"419","author":"J Levijoki","year":"2001","unstructured":"Levijoki J, Pollesello P, Kaheinen P, Haikala H. Improved survival with simendan after experimental myocardial infarction in rats. Eur J Pharmacol. 2001;419(2\u20133):243\u20138.","journal-title":"Eur J Pharmacol."},{"issue":"3","key":"2643_CR15","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1053\/j.jvca.2013.09.004","volume":"28","author":"A Baysal","year":"2014","unstructured":"Baysal A, Yanartas M, Dogukan M, Gundogus N, Kocak T, Koksal C. Levosimendan improves renal outcome in cardiac surgery: a randomized trial. J Cardiothorac Vasc Anesth. 2014;28(3):586\u201394.","journal-title":"J Cardiothorac Vasc Anesth."},{"issue":"5","key":"2643_CR16","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/bja\/aev284","volume":"115","author":"A Belletti","year":"2015","unstructured":"Belletti A, Castro ML, Silvetti S, Greco T, Biondi-Zoccai G, Pasin L, Zangrillo A, Landoni G. The Effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials. Br J Anaesth. 2015;115(5):656\u201375.","journal-title":"Br J Anaesth."},{"key":"2643_CR17","doi-asserted-by":"crossref","unstructured":"Landoni G, Biondi-Zoccai G, Greco M, Greco T, Bignami E, Morelli A, Guarracino F, Zangrillo A. Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies. Crit Care Med. 2012;40(2):634-646.","DOI":"10.1097\/CCM.0b013e318232962a"},{"issue":"6","key":"2643_CR18","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1053\/j.jvca.2013.03.027","volume":"27","author":"RW Harrison","year":"2013","unstructured":"Harrison RW, Hasselblad V, Mehta RH, Levin R, Harrington RA, Alexander JH. Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth. 2013;27(6):1224\u2013322.","journal-title":"J Cardiothorac Vasc Anesth."},{"issue":"5","key":"2643_CR19","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/bja\/aeu446","volume":"114","author":"T Greco","year":"2015","unstructured":"Greco T, Calabr\u00f2 MG, Covello RD, Greco M, Pasin L, Morelli A, Landoni G, Zangrillo A. A Bayesian network meta-analysis on the effect of inodilatory agents on mortality. Br J Anaesth. 2015;114(5):746\u201356.","journal-title":"Br J Anaesth."},{"issue":"2","key":"2643_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00134-014-3604-1","volume":"41","author":"G Koster","year":"2015","unstructured":"Koster G, Wetterslev J, Gluud C, Zijlstra JG, Scheeren TW, van der Horst IC, Keus F. Effects of levosimendan for low cardiac output syndrome in critically ill patients: systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 2015;41(2):203\u201321.","journal-title":"Intensive Care Med."},{"key":"2643_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijcard.2017.10.077","volume":"251","author":"A Putzu","year":"2018","unstructured":"Putzu A, Clivio S, Belletti A, Cassina T. Perioperative levosimendan in cardiac surgery: A systematic review with meta-analysis and trial sequential analysis. Int J Cardiol. 2018;251:22\u201331.","journal-title":"Int J Cardiol."},{"issue":"3","key":"2643_CR22","first-page":"125","volume":"17","author":"R Levin","year":"2012","unstructured":"Levin R, Degrange M, Del Mazo C, Tanus E, Porcile R. Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass. Exp Clin Cardiol. 2012;17(3):125\u201330.","journal-title":"Exp Clin Cardiol."},{"issue":"6","key":"2643_CR23","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2017.9973","volume":"318","author":"B Cholley","year":"2017","unstructured":"Cholley B, Caruba T, Grosjean S, Amour J, Ouattara A, Villacorta J, Miguet B, Guinet P, L\u00e9vy F, Squara P, Hamou NA. Effect of levosimendan on low cardiac output syndrome in patients with low ejection fraction undergoing coronary artery bypass grafting with cardiopulmonary bypass: the LICORN randomized clinical trial. JAMA. 2017;318(6):548\u201356.","journal-title":"JAMA."},{"issue":"21","key":"2643_CR24","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1056\/NEJMoa1616218","volume":"376","author":"RH Mehta","year":"2017","unstructured":"Mehta RH, Leimberger JD, van Diepen S, Meza J, Wang A, Jankowich R, Harrison RW, Hay D, Fremes S, Duncan A, Soltesz EG. Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery. N Engl J Med. 2017;376(21):2032\u201342.","journal-title":"N Engl J Med."},{"issue":"21","key":"2643_CR25","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1056\/NEJMoa1616325","volume":"376","author":"G Landoni","year":"2017","unstructured":"Landoni G, Lomivorotov VV, Alvaro G, Lobreglio R, Pisano A, Guarracino F, Calabr\u00f2 MG, Grigoryev EV, Likhvantsev VV, Salgado-Filho MF, Bianchi A. Levosimendan for hemodynamic support after cardiac surgery. N Engl J Med. 2017;376(21):2021\u201331.","journal-title":"N Engl J Med."},{"issue":"1","key":"2643_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/FJC.0000000000000551","volume":"71","author":"F Guarracino","year":"2018","unstructured":"Guarracino F, Heringlake M, Cholley B, Bettex D, Bouchez S, Lomivorotov VV, Rajek A, Kivikko M, Pollesello P. Use of levosimendan in cardiac surgery: an update after the LEVO\u2013CTS, CHEETAH, and LICORN trials in the light of clinical practice. J Cardiovasc Pharmacol. 2018;71(1):1\u20139. \n                              https:\/\/doi.org\/10.1097\/FJC.0000000000000551\n                              \n                           .","journal-title":"J Cardiovasc Pharmacol."},{"issue":"5","key":"2643_CR27","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.athoracsur.2017.11.027","volume":"105","author":"A Elbadawi","year":"2018","unstructured":"Elbadawi A, Elgendy IY, Saad M, Megaly M, Mentias A, Abuzaid AS, Shahin HI, Goswamy V, Abowali H, London B. Meta-analysis of trials on prophylactic use of levosimendan in patients undergoing cardiac surgery. Ann Thorac Surg. 2018;105(5):1403\u201310. \n                              https:\/\/doi.org\/10.1016\/j.athoracsur.2017.11.027\n                              \n                           .","journal-title":"Ann Thorac Surg."},{"key":"2643_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijcard.2016.02.014","volume":"209","author":"P Pollesello","year":"2016","unstructured":"Pollesello P, Parissis J, Kivikko M, Harjola VP. Levosimendan meta-analyses: is there a pattern in the effect on mortality? Int J Cardiol. 2016;209:77\u201383.","journal-title":"Int J Cardiol."},{"key":"2643_CR29","unstructured":"Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from: \n                              www.handbook.cochrane.org\n                              \n                           ."},{"issue":"7","key":"2643_CR30","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.","journal-title":"PLoS Med."},{"issue":"3","key":"2643_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1053\/j.jvca.2006.02.012","volume":"20","author":"E Al-Shawaf","year":"2006","unstructured":"Al-Shawaf E, Ayed A, Vislocky I, Radomir B, Dehrab N, Tarazi R. Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery. J Cardiothorac Vasc Anesth. 2006;20(3):353\u20137.","journal-title":"J Cardiothorac Vasc Anesth."},{"issue":"2","key":"2643_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4103\/aca.ACA_178_17","volume":"21","author":"PM Desai","year":"2018","unstructured":"Desai PM, Sarkar MS, Umbarkar SR. Prophylactic preoperative levosimendan for off-pump coronary artery bypass grafting in patients with left ventricular dysfunction: Single-centered randomized prospective study. Ann Card Anaesth. 2018;21(2):123\u20138. \n                              https:\/\/doi.org\/10.4103\/aca.ACA_178_17\n                              \n                           .","journal-title":"Ann Card Anaesth."},{"issue":"6","key":"2643_CR33","doi-asserted-by":"publisher","first-page":"E313","DOI":"10.1532\/HSF98.2014415","volume":"17","author":"V Sahin","year":"2014","unstructured":"Sahin V, Uyar IS, Gul I, Akpinar MB, Abacilar AF, Uc H, Okur FF, Tavli T, Ates M, Alayunt EA. Evaluation of myocardial contractility determination with tissue tracking echocardiography after levosimendan infusion in patients with poor left ventricular function and hemodynamics. Heart Surg Forum. 2014;17(6):E313\u20138. \n                              https:\/\/doi.org\/10.1532\/HSF98.2014415\n                              \n                           .","journal-title":"Heart Surg Forum."},{"issue":"14","key":"2643_CR34","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1001\/jama.291.14.1720","volume":"291","author":"JP Mathew","year":"2004","unstructured":"Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, Barash PG, Hsu PH, Mangano DT. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004;291(14):1720\u20139.","journal-title":"JAMA."},{"issue":"5","key":"2643_CR35","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1053\/j.jvca.2018.02.039","volume":"32","author":"A Zangrillo","year":"2018","unstructured":"Zangrillo A, Alvaro G, Belletti A, Pisano A, Brazzi L, Calabr\u00f2 MG, Guarracino F, Bove T, Grigoryev EV, Monaco F, Boboshko VA. Effect of levosimendan on renal outcome in cardiac surgery patients with chronic kidney disease and perioperative cardiovascular dysfunction: a substudy of a multicenter randomized trial. J Cardiothorac Vasc Anesth. 2018;32(5):2152\u20139.","journal-title":"J Cardiothorac Vasc Anesth."},{"issue":"5","key":"2643_CR36","doi-asserted-by":"publisher","first-page":"E287","DOI":"10.1532\/HSF98.2013190","volume":"16","author":"AF Abacilar","year":"2013","unstructured":"Abacilar AF, Dogan OF. Levosimendan use decreases atrial fibrillation in patients after coronary artery bypass grafting: a pilot study. Heart Surg Forum. 2013;16(5):E287\u201394.","journal-title":"Heart Surg Forum."},{"issue":"4","key":"2643_CR37","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1097\/00000542-199410000-00025","volume":"81","author":"PS Pagel","year":"1994","unstructured":"Pagel PS, Harkin CP, Hettrick DA, Warltier DC. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs. Anesthesiology. 1994;81(4):974\u201387.","journal-title":"Anesthesiology."},{"issue":"3","key":"2643_CR38","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S0008-6363(97)00057-6","volume":"34","author":"H Haikala","year":"1997","unstructured":"Haikala H, Kaheinen P, Levijoki J, Lind\u00e9n IB. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan. Cardiovasc Res. 1997;34(3):536\u201346.","journal-title":"Cardiovasc Res."},{"issue":"1","key":"2643_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejheart.2006.04.012","volume":"9","author":"J Lilleberg","year":"2007","unstructured":"Lilleberg J, Laine M, Palkama T, Kivikko M, Pohjanjousi P, Kupari M. Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure. Eur J Heart Fail. 2007;9(1):75\u201382.","journal-title":"Eur J Heart Fail."},{"issue":"18","key":"2643_CR40","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1161\/01.CIR.102.18.2222","volume":"102","author":"MT Slawsky","year":"2000","unstructured":"Slawsky MT, Colucci WS, Gottlieb SS, Greenberg BH, Haeusslein E, Hare J, Hutchins S, Leier CV, LeJemtel TH, Loh E, Nicklas J. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure: study investigators. Circulation. 2000;102(18):2222\u20137.","journal-title":"Circulation."},{"issue":"1","key":"2643_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1161\/01.CIR.0000043245.00859.11","volume":"107","author":"M Kivikko","year":"2003","unstructured":"Kivikko M, Lehtonen L, Colucci WS. Sustained hemodynamic effects of intravenous levosimendan. Circulation. 2003;107(1):81\u20136.","journal-title":"Circulation."},{"key":"2643_CR42","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ijcard.2015.02.022","volume":"184","author":"W Toller","year":"2015","unstructured":"Toller W, Heringlake M, Guarracino F, Algotsson L, Alvarez J, Argyriadou H, Ben-Gal T, \u010cern\u00fd V, Cholley B, Eremenko A, Guerrero-Orriach JL. Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion. Int J Cardiol. 2015;184:323\u201336.","journal-title":"Int J Cardiol."}],"container-title":["Journal of Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-019-02643-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00540-019-02643-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-019-02643-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T23:34:18Z","timestamp":1587684858000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00540-019-02643-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,25]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["2643"],"URL":"https:\/\/doi.org\/10.1007\/s00540-019-02643-3","relation":{},"ISSN":["0913-8668","1438-8359"],"issn-type":[{"value":"0913-8668","type":"print"},{"value":"1438-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,25]]},"assertion":[{"value":"18 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}